Medication

INDIANAPOLIS, Oct. 2, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food…

Upadacitinib (Rinvoq, AbbVie) was safe and efficacious out to 76 weeks in patients with nonsegmental vitiligo (NSV), with…

India’s drug-pricing system does not impose one uniform margin across all medicines. Instead, it operates through a mix…

Share on PinterestThe FDA initiated a second recall of its 25 mg chlorthalidone tablets this year, bringing the…

Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells,…

The decades-long journey to discovering the weight-loss drug that changed the world took an unlikely turn in an…

Thirty years ago, a small startup team of scientists in Boston published findings that began with the venom…

Listen to this article Estimated 2 minutes The audio version of this article is generated by AI-based technology.…

The Maharashtra Food and Drug Administration (FDA) on Friday said it has cancelled the drug sale and distribution…

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.…

A controversial proponent of natural remedies who has been banned from providing any health services in Australia is…

MIMRYLO works by helping to reduce red blood cell levels in people with the condition, supporting its control…

Lilly’s Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL